Randomized phase 2 dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma
-
Published:2024-09
Issue:
Volume:
Page:
-
ISSN:0923-7534
-
Container-title:Annals of Oncology
-
language:en
-
Short-container-title:Annals of Oncology
Author:
Agarwal N.ORCID,
Brugarolas J.,
Ghatalia P.,
George S.,
Haanen J.B.ORCID,
Gurney H.ORCID,
Ravilla R.ORCID,
Van der Veldt A.,
Beuselinck B.ORCID,
Pokataev I.,
Suelmann B.B.M.,
Tuthill M.H.,
Vaena D.,
Zagouri F.,
Wu J.,
Perini R.F.,
Liu Y.,
Merchan J.,
Atkins M.B.